Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Arcos Dorados Holdings
ARCO
$1.71B
| $3.82M | ﹤0.01% |
484,742
+136,842
| +39% | +$988K |
|
|
ALBO
2752
DELISTED
Albireo Pharma Inc
ALBO
| $3.81M | ﹤0.01% |
149,691
+42
| +0% | +$840 |
|
2753
Clarus
CLAR
$145M
| $3.8M | ﹤0.01% |
281,480
-49,328
| -15% | -$608K |
|
2754
Corbus Pharmaceuticals
CRBP
$195M
| $3.8M | ﹤0.01% |
23,192
+150
| +0.7% | +$22.2K |
|
2755
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $3.8M | ﹤0.01% |
4,316,222
-101,600
| -2% | -$8.84M |
|
|
BHR
2756
Braemar Hotels & Resorts
BHR
$139M
| $3.79M | ﹤0.01% |
424,660
+6,002
| +1% | +$56.1K |
|
|
PFNX
2757
DELISTED
Pfenex Inc.
PFNX
| $3.79M | ﹤0.01% |
344,870
-1,310
| -0.4% | -$13K |
|
2758
Seneca Foods Class A
SENEA
$1.31B
| $3.78M | ﹤0.01% |
92,742
-212
| -0.2% | -$7.64K |
|
|
KIN
2759
DELISTED
Kindred Biosciences, Inc.
KIN
| $3.78M | ﹤0.01% |
445,746
-8,084
| -2% | -$63.1K |
|
2760
Alpha and Omega Semiconductor
AOSL
$916M
| $3.77M | ﹤0.01% |
276,577
-9,766
| -3% | -$123K |
|
2761
Southern First Bancshares
SFST
$612M
| $3.75M | ﹤0.01% |
88,376
+2,612
| +3% | +$109K |
|
|
RRD
2762
DELISTED
RR Donnelley & Sons Co.
RRD
| $3.73M | ﹤0.01% |
944,410
-40,811
| -4% | -$161K |
|
2763
Cerence
CRNC
$389M
| $3.73M | ﹤0.01% |
+164,821
| New | +$2.7M |
|
2764
Alphatec Holdings
ATEC
$1.51B
| $3.73M | ﹤0.01% |
525,054
-14,233
| -3% | -$91.4K |
|
2765
Crinetics Pharmaceuticals
CRNX
$8.96B
| $3.73M | ﹤0.01% |
148,442
+12,793
| +9% | +$244K |
|
2766
First Bancorp
FNLC
$401M
| $3.72M | ﹤0.01% |
123,039
-814
| -0.7% | -$23.2K |
|
2767
El Pollo Loco
LOCO
$471M
| $3.7M | ﹤0.01% |
244,550
-21,714
| -8% | -$303K |
|
|
LL
2768
DELISTED
LL Flooring Holdings, Inc.
LL
| $3.7M | ﹤0.01% |
378,370
-6,017
| -2% | -$56.3K |
|
2769
AMES National
ATLO
$281M
| $3.7M | ﹤0.01% |
131,708
+23,986
| +22% | +$666K |
|
2770
Apyx Medical
APYX
$128M
| $3.69M | ﹤0.01% |
436,566
-73,421
| -14% | -$530K |
|
2771
Rayonier Advanced Materials
RYAM
$570M
| $3.68M | ﹤0.01% |
958,947
-10,375
| -1% | -$42.4K |
|
|
VNE
2772
DELISTED
Veoneer, Inc.
VNE
| $3.67M | ﹤0.01% |
234,771
+3,001
| +1% | +$48.3K |
|
|
ATCO
2773
DELISTED
Atlas Corp.
ATCO
| $3.67M | ﹤0.01% |
257,936
+23,711
| +10% | +$283K |
|
|
CNSL
2774
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $3.66M | ﹤0.01% |
942,239
+10,124
| +1% | +$38.9K |
|
2775
ASE Group
ASX
$103B
| $3.65M | ﹤0.01% |
657,373
+3,266
| +0.5% | +$16.8K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.